12-Lipoxygenase: classification, possible therapeutic benefits from inhibition, and inhibitors.
about
Eliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injuryImproved survival and reduced vascular permeability by eliminating or blocking 12/15-lipoxygenase in mouse models of acute lung injury (ALI).The flavonoid baicalein promotes NMDA receptor-dependent long-term potentiation and enhances memory.Bioactive lipid mediators in polycystic kidney diseaseDiscovery of potent and selective inhibitors of human reticulocyte 15-lipoxygenase-1.Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibitionHyperoxia causes maturation-dependent cell death in the developing white matter.Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2.Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism.Esterified eicosanoids: generation, characterization and function.Molecular biomarkers of lung carcinoma.Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Progress in Small Molecule Drug Development.Cytoprotective effect of honey against chromosomal breakage in fanconi anemia patients in vitro.Pyridine and pyrimidine analogs of acetaminophen as inhibitors of lipid peroxidation and cyclooxygenase and lipoxygenase catalysis.12-lipoxygenase activity plays an important role in PAR4 and GPVI-mediated platelet reactivity.
P2860
Q30418648-33A25D1E-94BC-43F6-BE9B-4D3A088D61A5Q30434669-0322786A-1674-44AB-A553-EFEE83843658Q30498748-7A78D3D8-9520-4554-AC15-141576352B87Q33653643-7BFBC2F7-1B2F-4C6D-8C83-113B92583987Q33702052-9E2D705C-8C9A-464E-8318-A883F9A91382Q34383455-763352DC-82D0-438B-8732-A48B37039766Q35009330-6031663E-7E47-4FBB-A51E-991E5B80B7E1Q36226027-D1EA393D-7473-4338-9692-49DCE4E9491DQ36932469-12B0269A-EA83-4A85-BC1A-22322013731CQ37971413-144CD71D-59DA-4712-9605-3258821CF246Q37971659-9AA718AF-04B9-4249-ACF2-3B49FBD7D116Q38974307-E767BCD4-3D6A-466D-A957-F4C6DCC9F896Q39047849-D8655819-4FBD-4A73-A0F7-7B7B842AC36CQ39761031-0E60106C-B942-46F7-ABAB-4BAAC476C913Q50893125-6D4B07FD-EAC4-47AA-9875-459110C5BB5E
P2860
12-Lipoxygenase: classification, possible therapeutic benefits from inhibition, and inhibitors.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@ast
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@en
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@nl
type
label
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@ast
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@en
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@nl
prefLabel
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@ast
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@en
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@nl
P1476
12-Lipoxygenase: classificatio ...... om inhibition, and inhibitors.
@en
P2093
P304
P577
1999-05-01T00:00:00Z